Divergent immunoglobulin g subclass activity through selective Fc receptor binding
- PMID: 16322460
- DOI: 10.1126/science.1118948
Divergent immunoglobulin g subclass activity through selective Fc receptor binding
Abstract
Subclasses of immunoglobulin G (IgG) display substantial differences in their ability to mediate effector responses, contributing to variable activity of antibodies against microbes and tumors. We demonstrate that the mechanism underlying this long-standing observation of subclass dominance in function is provided by the differential affinities of IgG subclasses for specific activating IgG Fc receptors compared with their affinities for the inhibitory IgG Fc receptor. The significant differences in the ratios of activating-to-inhibitory receptor binding predicted the in vivo activity. We suggest that these highly predictable functions assigned by Fc binding will be an important consideration in the design of therapeutic antibodies and vaccines.
Comment in
-
Immunology. Tipping the scales toward more effective antibodies.Science. 2005 Dec 2;310(5753):1442-3. doi: 10.1126/science.1122009. Science. 2005. PMID: 16322444 No abstract available.
Similar articles
-
FcgammaRIV: a novel FcR with distinct IgG subclass specificity.Immunity. 2005 Jul;23(1):41-51. doi: 10.1016/j.immuni.2005.05.010. Immunity. 2005. PMID: 16039578
-
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.Cancer Res. 2007 Sep 15;67(18):8882-90. doi: 10.1158/0008-5472.CAN-07-0696. Cancer Res. 2007. PMID: 17875730
-
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.Proc Natl Acad Sci U S A. 2007 May 15;104(20):8433-7. doi: 10.1073/pnas.0702936104. Epub 2007 May 7. Proc Natl Acad Sci U S A. 2007. PMID: 17485663 Free PMC article.
-
A newly discovered Fc receptor that explains IgG-isotype disparities in effector responses.Immunity. 2005 Jul;23(1):2-4. doi: 10.1016/j.immuni.2005.07.002. Immunity. 2005. PMID: 16039573 Review.
-
Effector mechanisms activated by human IgG subclass antibodies: clinical and molecular aspects. Review article.Ann Biol Clin (Paris). 1994;52(1):57-65. Ann Biol Clin (Paris). 1994. PMID: 8210076 Review.
Cited by
-
Polymeric human Fc-fusion proteins with modified effector functions.Sci Rep. 2011;1:124. doi: 10.1038/srep00124. Epub 2011 Oct 19. Sci Rep. 2011. PMID: 22355641 Free PMC article.
-
Modulating Antibody Functionality in Infectious Disease and Vaccination.Trends Mol Med. 2016 Nov;22(11):969-982. doi: 10.1016/j.molmed.2016.09.002. Epub 2016 Oct 15. Trends Mol Med. 2016. PMID: 27756530 Free PMC article. Review.
-
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes.Nat Mater. 2012 Jan 22;11(3):250-7. doi: 10.1038/nmat3222. Nat Mater. 2012. PMID: 22266469 Free PMC article.
-
Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model.Front Immunol. 2024 Jun 19;15:1392043. doi: 10.3389/fimmu.2024.1392043. eCollection 2024. Front Immunol. 2024. PMID: 38962015 Free PMC article.
-
Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice.PLoS Pathog. 2009 Dec;5(12):e1000690. doi: 10.1371/journal.ppat.1000690. Epub 2009 Dec 11. PLoS Pathog. 2009. PMID: 20011127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
